As expected, we found that the percentage of GATA6+ PRMs markedly decreased at week 3 after MC38 tumor inoculation in mice treated with ODN1585 only or ODN+anti–PD-1 compared with mice that received control isotype antibody and anti–PD-1 (Figure 4D). Here, GATA6 is linked to neoplasm.